 |
UK genome editing market, by
end-use, 2014 - 2025 (USD Million)
The global genome editing market is anticipated to reach
USD 8.1 billion by 2025, according to a new report by Grand View Research, Inc.
Key drivers attributing to the expansion include early applications of DNA
editing to therapeutics. Use of the technology for the disease eradication
through direct correction of disturbances in normal physiology, engineering the
immune response, and alteration of pathogen targets in the host is anticipated
to drive the market with substantial opportunities.
The ability of genome editing
therapies to offer a significant improvement over current treatment options is
important in enabling editing technologies to capture significant revenue
share. Improved efficacy, reduced side effects, and the potential for cure for
specific diseases, can be attributed to induce growth in the coming
years.
Moreover, technological
advancements with respect to the development of novel vectors for delivery is
anticipated to fuel growth in the coming years. Rising competition amongst the
operating entities in order to gain the larger share of revenue is also
responsible for the projected growth. These companies leverage industry
collaborations for the acceleration of diversified product pipelines.
Full Research Report On Genome Editing Market Analysis:
http://www.grandviewresearch.com/industry-analysis/genome-editing-market
http://www.grandviewresearch.com/industry-analysis/genome-editing-market
Further Key Findings from the Report Suggest:
·
There has been great excitement
surrounding the highly adaptable CRISPR technology.
·
The increased ease of
retargeting and the ability to multiplex goes a long way toward explaining the
speed with which CRISPR-centric companies have sprung up.
·
Ex-vivo mode of delivery
accounted for the largest share of the revenue.
·
Therapy through ex-vivo mode of
delivery allow the control over the specific dosage of therapeutic molecules
delivered to cells.
·
Cell line engineering dominated
with respect to revenue generation owing to the high utilization of technology
in stem cell engineering.
·
There is comparatively, higher
adoption of the technology in the biotechnology and pharmaceutical
organizations for the purpose of therapeutic development.
·
Availability of other services
such as gRNA library production and screening service along with editing is
anticipated to propel growth in the outsourcing services.
·
Asia Pacific is anticipated to
witness fastest growth over the forecast period owing to rising penetration of
technology in comparatively immature market.
·
Key players contributing in
this market are Thermo Fisher Scientific, Inc., Sangamo, Editas Medicine,
Recombinetics, Inc, Sigma Aldrich Corporation, CRISPR THERAPEUTICS, Intellia
Therapeutics, Inc., Caribou Biosciences, Inc.
·
These participants are
capitalizing on unique advantages offered by the nuclease technology, they are
working on.
View More Reports Of This Category By Grand
View Research At: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
molecular scissors/genome editing market on the basis of technology, delivery
method, application, end-use, service, and region:
Molecular Scissors/Genome
Editing Technology Outlook (Revenue, USD Million, 2014 - 2025)
·
(CRISPR)/Cas9
·
TALENs/MegaTALs
·
ZFN
·
Others
Molecular Scissors/Genome
Editing Delivery Method Outlook (Revenue, USD Million, 2014 - 2025)
·
Ex-Vivo
·
In-Vivo
Molecular Scissors/Genome
Editing Application Outlook (Revenue, USD Million, 2014 - 2025)
·
Cell Line Engineering
·
Animal Genetic Engineering
·
Plant Genetic Engineering
·
Other Applications
Molecular Scissors/Genome
Editing End-use Outlook (Revenue, USD Million, 2014 - 2025)
·
Biotechnology &
Pharmaceutical Companies
·
Academic & Government
Research Institutes
·
Contract Research Organizations
Molecular Scissors/Genome
Editing Service Outlook (Revenue, USD Million, 2014 - 2025)
·
Contract
·
In-house
Molecular Scissors/Genome
Editing Service Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
·
Middle East and Africa (MEA)
o
South Africa
Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-genome-editing-market
https://www.grandviewresearch.com/press-release/global-genome-editing-market
About Grand View
Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/
